June 23, 2020 by Chain Drug Review
Murray Kessler, Perrigo, Rosemont Pharmaceuticals
Business, Leading Headlines, Pharmacy, Supplier News
DUBLIN —Perrigo Co. has reached a definitive agreement to sell its U.K.-based Rosemont Pharmaceuticals business, a generic prescription pharmaceuticals manufacturer focused on liquid medicines, to a U.K.-headquartered private equity firm for £156 million or approximately $195 million in cash. This transaction, which was signed and closed on the same day, represents another step in Perrigo’s transformation
June 17, 2020 by Chain Drug Review
CBD, Kazmira, Perrigo
Supplier News
DUBLIN — Perrigo has entered into the CBD market through a strategic investment in and long-term supply agreement with Kazmira, a leading supplier of hemp-based CBD products free of tetrahydrocannabinol (“THC-free”) based in Watkins, Colorado. The fast-growing and rapidly evolving CBD market is emerging organically in response to changing consumer preferences for natural remedies and
February 26, 2020 by Chain Drug Review
B-rated generic version of ProAir HFA, Catalent Pharma Solutions, Generic albuterol sulfate inhalation aeroso, Perrigo
Pharmacy, Supplier News
DUBLIN – Perrigo and its partner, Catalent Pharma Solutions, Wednesday announced that the U.S. Food and Drug Administration (FDA) has approved Perrigo’s abbreviated new drug application for generic albuterol sulfate inhalation aerosol, the first AB-rated generic version of ProAir HFA. Perrigo is launching a limited quantity of generic albuterol sulfate inhalation aerosol and, in collaboration
October 23, 2019 by Chain Drug Review
Jeremy Jones., Perrigo, Perrigo Nutrition, Wakefield Research
Business, Leading Headlines, Supplier News
CHARLOTTESVILLE, Va. — Perrigo Pediatrics — a pediatrician-support program by U.S. infant formula maker Perrigo — and Wakefield Research, released findings Wednesday from a nationwide survey of 500 U.S. pediatricians that explored top concerns and perceptions around safe infant formula feeding practices. According to the survey, pediatricians report that parents are making unsafe infant-feeding choices
July 2, 2019 by Chain Drug Review
Murray Kessler, Perrigo, Ranir
Business, Leading Headlines, Supplier News
DUBLIN — Perrigo announced Tuesday the successful completion of its acquisition of Ranir, a leading global store brand supplier of oral self-care products, for $750 million in cash. This transaction advances Perrigo’s transformation to a consumer-focused, self-care company while enhancing its position as a global leader in consumer self-care solutions. Perrigo chief executive officer and
December 3, 2018 by Chain Drug Review
Michael Bachman, Omeprazole, Omeprazole ODT, Perrigo, The national "Beating the Holiday Burn" survey, Tom Kersting
Leading Headlines, Pharmacy, Supplier News
ALLEGAN, Mich. — While the holidays are synonymous with peace, love and joy for many Americans who celebrate, the holiday season is actually filled with physical and emotional discomfort, according to a new survey commissioned by the distributor of store brand Omeprazole Delayed Release Orally Disintegrating Tablets 20 mg (Omeprazole ODT). The national “Beating the Holiday
October 5, 2018 by Chain Drug Review
Amazon, First Quality, Mama Bear diapers, One Click Retail, Perrigo, Peter Andrews, Private Label Brands
Leading Headlines, Retail News
SALT LAKE CITY — Private brand expansion has been a major priority for Amazon with several new labels being introduced every year. According to a new report by eCommerce analytics provider One Click Retail, Amazon is now slowing their private brand expansion in favor of introducing a number of Amazon-exclusive brands. Unlike Amazon-owned private labels, these brands
March 7, 2018 by Chain Drug Review
guaifenesin and dextromethorphan hydrobromide extended-release tablets, Jeff Needham, Mucinex DM Maximum Strength, Perrigo
Pharmacy, Supplier News
DUBLIN, Ireland — Perrigo Co. has been cleared by the Food and Drug Administration to market over-the-counter guaifenesin and dextromethorphan hydrobromide extended-release tablets 1200 mg/60 mg, an expectorant and cough suppressant. Perrigo said Wednesday that its guaifenesin and dextromethorphan ER tablets are an OTC generic version of Mucinex DM Maximum Strength tablets from Reckitt Benckiser. Plans call
February 21, 2018 by Chain Drug Review
Amazon Basic Care, Basic Care, over-the-counter health products market, Perrigo, video
Leading Headlines, Videos
Amazon.com has made an own-brand foray into the over-the-counter health products market. Published reports said Amazon has quietly introduced a line of OTCs under the Basic Care brand, including items provided by Ireland-based store-brand and generic drug maker Perrigo plc, whose Good Sense private-label products already were sold by the e-tailing giant. The first
September 22, 2017 by Chain Drug Review
generic verison of Exalgo, hydromorphone HCl extended-release tablets, John Wesolowski, Perrigo
Pharmacy, Supplier News
DUBLIN, Ireland — Perrigo Co. plc has received approval from the Food and Drug Administration for hydromorphone HCl extended-release tablets 32 mg, an opioid pain medication. Perrigo said it expects to launch its hydromorphone product, a generic verison of Exalgo 32-mg ER tablets from Mallinckrodt, by the end of this month. An opioid agonist, Exalgo
August 16, 2017 by Chain Drug Review
generic version of Mycolog II Cream, Mycolog II Cream, Mycolog II Cream generic, nystatin and triamcinolone acetonide cream, Perrigo
Supplier News
DUBLIN, Ireland — Perrigo Co. plc has received approval from the Food and Drug Administration for nystatin and triamcinolone acetonide cream 100,000 units/gram and 1 mg/gram, an antifungal medication. The company said Wednesday that its nystatin and triamcinolone acetonide product is a generic version of Mycolog II Cream from Bristol-Myers Squibb. The branded product was
June 6, 2017 by Chain Drug Review
John Hendrickson, Joseph Papa, Laurie Brlas, Perrigo
Business, Pharmacy, Supplier News
DUBLIN, Ireland — John Hendrickson, chief executive officer Perrigo Co. plc, plans to retire from the company after just over a year in the CEO role. Perrigo said late Monday that Hendrickson will remain with the company until his replacement is appointed and up to 60 days thereafter to assist with the transition. Plans call
March 9, 2017 by Chain Drug Review
John Hendrickson, minoxidil topical aerosol foam 5%, Perrigo, store-brand version of Women's Rogaine, Women's Rogaine
Pharmacy, Supplier News
DUBLIN, Ireland — Perrigo Co. plc has begun shipping a store-brand version of Women’s Rogaine, a foam hair regrowth treatment. Perrigo said it’s the first to market with an over-the-counter, private-label version of minoxidil topical aerosol foam 5%. The product is packaged and marketed as a store brand or retailer “own label brand and provides
February 22, 2017 by Chain Drug Review
hydrocodone bitartrate and homatropine methylbromide oral solution, hydrocodone bitartrate and homatropine methylbromide syrup, John Hendrickson, Perrigo
Pharmacy, Supplier News
DUBLIN, Ireland — Perrigo Co. plc has received approval from the Food and Drug Administration for hydrocodone bitartrate and homatropine methylbromide oral solution 5 mg/1.5 mg per 5 ml. Hydrocodone bitartrate and homatropine methylbromide syrup is indicated for the symptomatic relief of cough in adults and children ages 6 and older. A combination medication, the
